XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based and Other Long-Term Incentive Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Expense
The following table summarizes the total stock-based compensation expense recognized during the periods presented:
Three months ended March 31,
20252024
Equity-classified$359 $274 
Liability-classified (1)
— — 
$359 $274 
(1)    Represents compensation expense associated with awards that may be settled in cash at the option of the grantee including a nominal amount (less than $1 thousand) during the 2025 period and none during the 2024 period.
Schedule of Option Activity A summary of all option activity during the three months ended March 31, 2025 is presented below:
Number of Shares Underlying
Stock Options
Weighted Average
Exercise
 Price
Weighted
Average
Remaining
Contractual Life (years)
Aggregate
Intrinsic
Value
Outstanding, December 31, 2024113,751 $20.44 5.84$747 
Granted40,250 $22.19 $— 
Exercised— $— $— 
Canceled/Forfeited(2,833)$21.57 $16 
Expired— $— $— 
Outstanding, March 31, 2025151,168 $20.89 6.69$344 
Exercisable, March 31, 202564,921 $19.98 3.08$261 
Schedule of Stock Options Outstanding
The following table summarizes information about our stock options outstanding as of March 31, 2025:
 
Range of Exercise Prices:
Options Outstanding
Options Exercisable
Shares
Weighted
Average
Remaining
Contractual
Life (years)
Weighted
Average
Exercise
Price
Shares
Weighted
Average
Exercise
Price
$0.01-$18.00
29,501 6.99$10.72 22,835 $10.68 
$18.01-$26.00
5,000 9.38$19.50 1,169 $19.65 
$26.01-$30.00
116,667 6.49$23.51 40,917 $25.18 
151,168 6.69$20.89 64,921 $19.98 
Schedule of Status of Unvested Stock Options
The following table summarizes changes in our unvested stock options during the three months ended March 31, 2025:
SharesWeighted Average Grant Date Fair Value Per Share
Unvested, December 31, 2024
48,998 $11.35 
Granted40,250 $12.06 
Vested
(501)$10.45 
Canceled/Forfeited(2,500)$12.46 
Unvested, March 31, 2025
86,247 $11.65 
Schedule of Restricted Stock Activity
The following table summarizes all restricted stock and RSU activity during the three months ended March 31, 2025 is presented below:
 Number
 of
Shares
Weighted Average
Grant Date Fair Value
Weighted
Average
Remaining
Contractual Life (years)
Aggregate
Intrinsic
Value
Outstanding, December 31, 2024131,183 $16.39 5.15$3,516 
Granted55,859 $22.19 $1,240 
Exercised(22,891)$15.46 $580 
Canceled/Forfeited— $— $— 
Outstanding, March 31, 2025164,151 $18.50 4.81$3,606 
 Number
 of
Shares
Weighted Average
Grant Date Fair Value
Weighted
Average
Remaining
Contractual Life (years)
Aggregate
Intrinsic
Value
Outstanding, December 31, 202415,069 $19.51 0.50$294 
Granted— $— 
Vested— $— 
Canceled/Forfeited(2,810)$19.57 $55 
Outstanding, March 31, 202512,259 $19.50 0.30$239 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The following table summarizes the weighted average grant date fair values of PSUs granted and the assumptions used in the Monte Carlo simulation model for the determination of the grant date fair values of our PSUs granted during the three months ended March 31, 2025:
Weighted-average grant date fair value of PSUs granted$28.05 
Risk free rate3.93 %
Expected volatility43.9 %
Expected dividend yield— %
Schedule of PSU Activity
The following table summarizes all PSU activity during the three months ended March 31, 2025:
Number
 of
Shares
Weighted Average
Grant Date Fair Value
Weighted
Average
Remaining
Contractual Life (years)
Aggregate
Intrinsic
Value
Outstanding, December 31, 202456,764 $22.47 2.22$— 
Granted39,434 $28.05 $— 
Vested— $— 
Canceled/Forfeited— $— 
Outstanding, March 31, 202596,198 $24.76 2.38$—